These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 36714110)

  • 21. COVID-19 vaccine waning and effectiveness and side-effects of boosters: a prospective community study from the ZOE COVID Study.
    Menni C; May A; Polidori L; Louca P; Wolf J; Capdevila J; Hu C; Ourselin S; Steves CJ; Valdes AM; Spector TD
    Lancet Infect Dis; 2022 Jul; 22(7):1002-1010. PubMed ID: 35405090
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predictors of COVID-19 booster vaccine hesitancy among fully vaccinated adults in Korea: a nationwide cross-sectional survey.
    Noh Y; Kim JH; Yoon D; Choe YJ; Choe SA; Jung J; Lee SW; Shin JY
    Epidemiol Health; 2022; 44():e2022061. PubMed ID: 35914771
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety Monitoring of Bivalent COVID-19 mRNA Vaccine Booster Doses Among Children Aged 5-11 Years - United States, October 12-January 1, 2023.
    Hause AM; Marquez P; Zhang B; Su JR; Myers TR; Gee J; Panchanathan SS; Thompson D; Shimabukuro TT; Shay DK
    MMWR Morb Mortal Wkly Rep; 2023 Jan; 72(2):39-43. PubMed ID: 36634021
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Determinants of COVID-19 Vaccine Hesitancy: A Cross-Sectional Study on a Mexican Population Using an Online Questionnaire (COV-AHQ).
    Delgado-Gallegos JL; Padilla-Rivas GR; Zúñiga-Violante E; Avilés-Rodríguez G; Arellanos-Soto D; Gastelum-Arias LJ; Franco Villareal H; Cosío-León MLÁ; Romo-Cardenas GS; Moreno-Treviño MG; Moreno-Cuevas JE; Islas JF
    Front Public Health; 2021; 9():728690. PubMed ID: 34900890
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Social Attitudes Towards the Booster Dose of the COVID-19 Vaccine and the Associated Factors Among Residents of Riyadh, Saudi Arabia.
    Alyahya K; Almousa WY; Binsalamh LF; Alturaifi GA; Alabdely LH; Aljulaihim NF; Aldosari LM
    Cureus; 2023 Oct; 15(10):e46556. PubMed ID: 37933360
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evidence synthesis and pooled analysis of vaccine effectiveness for COVID-19 mRNA vaccine BNT162b2 as a heterologous booster after inactivated SARS-CoV-2 virus vaccines.
    Kyaw MH; Spinardi J; Zhang L; Oh HML; Srivastava A
    Hum Vaccin Immunother; 2023 Dec; 19(1):2165856. PubMed ID: 36727201
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Association between Risk Perception and Hesitancy toward the Booster Dose of COVID-19 Vaccine among People Aged 60 Years and Older in China.
    Qin C; Yan W; Tao L; Liu M; Liu J
    Vaccines (Basel); 2022 Jul; 10(7):. PubMed ID: 35891277
    [TBL] [Abstract][Full Text] [Related]  

  • 28. COVID-19 vaccine hesitancy and acceptance: a comprehensive scoping review of global literature.
    Majid U; Ahmad M; Zain S; Akande A; Ikhlaq F
    Health Promot Int; 2022 Jun; 37(3):. PubMed ID: 35788306
    [TBL] [Abstract][Full Text] [Related]  

  • 29. COVID-19 Vaccine Hesitancy-A Scoping Review of Literature in High-Income Countries.
    Aw J; Seng JJB; Seah SSY; Low LL
    Vaccines (Basel); 2021 Aug; 9(8):. PubMed ID: 34452026
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk factors related to the SARS-CoV-2 vaccine additional doses hesitancy among pregnant and non-pregnant people of reproductive age and partners: A Brazilian cross-sectional study.
    Charles CM; Noles M; Munezero A; Gallardo N; Bahamondes L; Bento SF; de Pádua KS; Nhauche M; Metelus S; Cecatti JG; Souza RT; Pacagnella RC
    Int J Gynaecol Obstet; 2024 Mar; ():. PubMed ID: 38532554
    [TBL] [Abstract][Full Text] [Related]  

  • 31. COVID-19 Vaccine Booster Hesitancy (VBH) and Its Drivers in Algeria: National Cross-Sectional Survey-Based Study.
    Lounis M; Bencherit D; Rais MA; Riad A
    Vaccines (Basel); 2022 Apr; 10(4):. PubMed ID: 35455371
    [TBL] [Abstract][Full Text] [Related]  

  • 32. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.
    Meo SA; Bukhari IA; Akram J; Meo AS; Klonoff DC
    Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1663-1669. PubMed ID: 33629336
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A matter of trust: a qualitative comparison of the determinants of COVID-19 vaccine hesitancy in Taiwan, the United States, the Netherlands, and Haiti.
    Wang CW; de Jong EP; Faure JA; Ellington JL; Chen CS; Chan CC
    Hum Vaccin Immunother; 2022 Nov; 18(5):2050121. PubMed ID: 35349382
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Barriers and facilitators of childhood COVID-19 vaccination among parents: A systematic review.
    Khan YH; Rasheed M; Mallhi TH; Salman M; Alzarea AI; Alanazi AS; Alotaibi NH; Khan SU; Alatawi AD; Butt MH; Alzarea SI; Alharbi KS; Alharthi SS; Algarni MA; Alahmari AK; Almalki ZS; Iqbal MS
    Front Pediatr; 2022; 10():950406. PubMed ID: 36507133
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Parental hesitancy towards vaccinating their children with a booster dose against COVID-19: Real-world evidence from Taizhou, China.
    Huang LL; Yang YP; Mao HP; Hu WW; Jiang YH; Jiesisibieke ZL; Tung TH
    J Infect Public Health; 2022 Sep; 15(9):1006-1012. PubMed ID: 35987122
    [TBL] [Abstract][Full Text] [Related]  

  • 36. COVID-19 vaccine acceptance, hesitancy, and determinants among physicians in a university-based teaching hospital in Thailand.
    Sirikalyanpaiboon M; Ousirimaneechai K; Phannajit J; Pitisuttithum P; Jantarabenjakul W; Chaiteerakij R; Paitoonpong L
    BMC Infect Dis; 2021 Nov; 21(1):1174. PubMed ID: 34809607
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acceptance of the COVID-19 vaccine booster dose and associated factors among the elderly in China based on the health belief model (HBM): A national cross-sectional study.
    Qin C; Yan W; Du M; Liu Q; Tao L; Liu M; Liu J
    Front Public Health; 2022; 10():986916. PubMed ID: 36589991
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative effectiveness of bivalent BA.4-5 and BA.1 mRNA booster vaccines among adults aged ≥50 years in Nordic countries: nationwide cohort study.
    Andersson NW; Thiesson EM; Baum U; Pihlström N; Starrfelt J; Faksová K; Poukka E; Meijerink H; Ljung R; Hviid A
    BMJ; 2023 Jul; 382():e075286. PubMed ID: 37491022
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effectiveness of a COVID-19 Additional Primary or Booster Vaccine Dose in Preventing SARS-CoV-2 Infection Among Nursing Home Residents During Widespread Circulation of the Omicron Variant - United States, February 14-March 27, 2022.
    Prasad N; Derado G; Nanduri SA; Reses HE; Dubendris H; Wong E; Soe MM; Li Q; Dollard P; Bagchi S; Edwards J; Shang N; Budnitz D; Bell J; Verani JR; Benin A; Link-Gelles R; Jernigan J; Pilishvili T
    MMWR Morb Mortal Wkly Rep; 2022 May; 71(18):633-637. PubMed ID: 35511708
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Trajectory of COVID-19 vaccine hesitancy post-vaccination and public's intention to take booster vaccines: A cross-sectional analysis.
    Salman M; Mallhi TH; Khan YH; Mustafa ZU; Khan MT; Khan FU; Butt MH; Shehzadi N; Farrukh MJ; Waheed M; Azmat F; Saeed A; Mazhar SA; Ali A; Ashfaq A; Hussain K
    Hum Vaccin Immunother; 2023 Aug; 19(2):2225990. PubMed ID: 37350298
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.